Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for recovery after breast cancer surgery
NCT03676114Phase 4Unknown
- Sponsor
- Hanyuan Bio
- Start
- Sep 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in postoperative pain, anxiety disorder, major depressive disorder (MDD), fatigue, sponsored by Hanyuan Bio. Status: unknown.
02
Drugs
ketamine
03
Conditions
postoperative painanxiety disordermajor depressive disorder (MDD)fatigue
Beyond the preview
Go deeper on NCT03676114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676114.